latest update:
[TrialBase DB]

trial summary · NCT07417111

Continued Pressure for Alveolar Protection (CPAP Trial)

Continued Pressure for Alveolar Protection: A Randomized Controlled Trial (CPAP Trial)

Trial record from the TrialBase DB dataset, status RECRUITING, condition Bronchopulmonary Dysplasia (BPD), sponsored by NICHD Neonatal Research Network. Facts below are exported values from the current release, not inferred or edited prose.

registry NCT07417111phase —enrollment 860start 2026-11-05

Summary

The brief summary is the registry's published description, capped for length. Field definitions, types, and provenance rules are in the data dictionary.

The objective of the CPAP Trial is to test whether extending CPAP until 34 weeks' PMA or for at least 2 additional weeks compared to weaning to a nasal canula will decrease the likelihood of bronchopulmonary dysplasia or death at 36 weeks' PMA.

Source record: https://clinicaltrials.gov/study/NCT07417111

Facts

registry idNCT07417111
primary registryclinicaltrials-gov
recruitment statusRECRUITING
phasenot reported
study typeINTERVENTIONAL
lead conditionBronchopulmonary Dysplasia (BPD)
sponsorNICHD Neonatal Research Network
sponsor classNETWORK
enrollment860
start date2026-11-05
primary completion2028-11-05
completion2029-01-30
results postednot reported

Conditions

  • Bronchopulmonary Dysplasia (BPD)

Interventions

  • CPAP
  • Nasal Cannula

Countries

  • United States

Intervention types: DEVICE

Work with this record